Monarch Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Sell
1,108
-22
-2% -$22.5K 0.3% 73
2026
Q1
$1.04M Sell
1,130
-30
-3% -$30.4K 0.25% 73
2025
Q4
$1.25M Sell
1,160
-149
-11% -$142K 0.31% 69
2025
Q3
$999K Sell
1,309
-310
-19% -$231K 0.24% 72
2025
Q2
$1.26M Buy
1,619
+245
+18% +$190K 0.34% 65
2025
Q1
$1.13M Buy
1,374
+6
+0.4% +$4.99K 0.32% 65
2024
Q4
$1.06M Buy
1,368
+206
+18% +$171K 0.29% 65
2024
Q3
$1.03M Hold
1,162
0.28% 66
2024
Q2
$1.05M Buy
1,162
+27
+2% +$21.6K 0.31% 66
2024
Q1
$883K Buy
1,135
+23
+2% +$16.4K 0.25% 70
2023
Q4
$648K Sell
1,112
-14
-1% -$8.17K 0.2% 76
2023
Q3
$605K Sell
1,126
-50
-4% -$25.8K 0.19% 74
2023
Q2
$552K Hold
1,176
0.17% 81
2023
Q1
$404K Sell
1,176
-313
-21% -$106K 0.12% 94
2022
Q4
$545K Hold
1,489
0.17% 79
2022
Q3
$481K Sell
1,489
-40
-3% -$12.7K 0.16% 82
2022
Q2
$496K Sell
1,529
-20
-1% -$6K 0.15% 84
2022
Q1
$444K Hold
1,549
0.12% 92
2021
Q4
$428K Hold
1,549
0.11% 94
2021
Q3
$358K Sell
1,549
-130
-8% -$32.1K 0.1% 98
2021
Q2
$385K Hold
1,679
0.11% 96
2021
Q1
$314K Sell
1,679
-50
-3% -$9.78K 0.09% 96
2020
Q4
$292K Hold
1,729
0.09% 95
2020
Q3
$256K Hold
1,729
0.09% 93
2020
Q2
$284K Sell
1,729
-646
-27% -$99.2K 0.1% 87
2020
Q1
$329K Sell
2,375
-1,400
-37% -$192K 0.13% 81
2019
Q4
$496K Hold
3,775
0.16% 75
2019
Q3
$422K Sell
3,775
-100
-3% -$11.1K 0.15% 76
2019
Q2
$429K Sell
3,875
-300
-7% -$35.3K 0.15% 76
2019
Q1
$542K Sell
4,175
-548
-12% -$66.6K 0.2% 72
2018
Q4
$547K Hold
4,723
0.22% 69
2018
Q3
$507K Sell
4,723
-500
-10% -$50K 0.18% 74
2018
Q2
$446K Hold
5,223
0.17% 77
2018
Q1
$404K Buy
5,223
+150
+3% +$12.1K 0.16% 76
2017
Q4
$428K Sell
5,073
-600
-11% -$51.1K 0.16% 74
2017
Q3
$485K Hold
5,673
0.18% 71
2017
Q2
$467K Hold
5,673
0.18% 73
2017
Q1
$477K Hold
5,673
0.17% 71
2016
Q4
$417K Hold
5,673
0.16% 77
2016
Q3
$455K Hold
5,673
0.17% 73
2016
Q2
$447K Hold
5,673
0.17% 75
2016
Q1
$409K Hold
5,673
0.15% 80
2015
Q4
$478K Hold
5,673
0.18% 73
2015
Q3
$475K Sell
5,673
-900
-14% -$76K 0.19% 73
2015
Q2
$549K Sell
6,573
-700
-10% -$53.3K 0.21% 71
2015
Q1
$528K Hold
7,273
0.2% 73
2014
Q4
$502K Sell
7,273
-500
-6% -$33.8K 0.19% 73
2014
Q3
$504K Sell
7,773
-3,000
-28% -$190K 0.2% 71
2014
Q2
$670K Buy
10,773
+333
+3% +$19.9K 0.26% 66
2014
Q1
$614K Buy
10,440
+400
+4% +$22.3K 0.24% 67
2013
Q4
$512K Hold
10,040
0.2% 66
2013
Q3
$505K Sell
10,040
-600
-6% -$31.4K 0.21% 66
2013
Q2
$523K Buy
+10,640
New +$579K 0.23% 65

Other funds holding LLY

Monarch Capital Management's LLY Position: Q2 2026 in Review

Monarch Capital Management reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $22.5K and leaving 1,108 shares worth $1.33M. The position accounts for 0.3% of the portfolio, ranked #73.

Monarch Capital Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,717 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Monarch Capital Management held 1,108 shares of Eli Lilly worth $1.33M as of Q2 2026.
  • Monarch Capital Management sold 22 Eli Lilly shares in Q2 2026, an estimated $22.5K.
  • Eli Lilly made up 0.3% of Monarch Capital Management's portfolio in Q2 2026, its #73 holding.
  • Monarch Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 1,717 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Monarch Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.